Related Experiment Video
Updated: Jan 20, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Advanced Molecular Tweezers Effectively Target Membranes Lacking Choline Headgroups for Broad-Spectrum Antiviral
Tatjana Weil1, Jan Lawrenz1, Estelle Taghuo Kaptouom2
1Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany.
Advanced molecular tweezers show broad-spectrum antiviral activity by disrupting viral envelopes through dual mechanisms: choline binding and hydrophobic insertion. This dual action enhances their potential as novel prophylactic and therapeutic antivirals.
Area of Science:
- Membrane biophysics
- Virology
- Medicinal chemistry
Background:
- Broad-spectrum antivirals are crucial for combating viral threats.
- Parental molecular tweezers (CLR01, CLR05) disrupt viral envelopes by binding choline headgroups.
- Ester-functionalized "advanced" tweezers exhibit enhanced antiviral potency.
Purpose of the Study:
- To elucidate the molecular basis for the enhanced antiviral activity of advanced molecular tweezers.
- To understand the mechanism of action of advanced tweezers against viral envelopes.
Main Methods:
- Liposome leakage assays
- Giant unilamellar vesicles (GUVs)
- Nuclear Magnetic Resonance (NMR)
- Langmuir film balance experiments
- Atomistic simulations
Main Results:
- Advanced tweezers bind not only choline-containing lipids but also engage lipids lacking choline via hydrophobic insertion.
- These interactions destabilize membranes enriched in sphingomyelin, unsaturated acyl chains, or inverted cone-shaped lipids.
- The mechanism is particularly effective against small, highly curved lipid particles, similar to viral particles.
Conclusions:
- Advanced molecular tweezers possess a dual mechanism of action: choline binding and hydrophobic insertion.
- This dual mechanism underpins their broad-spectrum antiviral activity against enveloped viruses.
- Advanced molecular tweezers represent a promising new class of membrane-targeting antivirals for prophylaxis and therapy.
Related Concept Videos
11:34High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
02:48Determining Antiviral Efficacy of Experimental Drugs Through a Plaque Assay
06:03Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
08:31Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
12:02Assays for the Identification of Novel Antivirals against Bluetongue Virus
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

